Risk-Based Quality Management in Medical Devices: ISO 14155 vs ICH E6(R3)
Medical device investigations are now assessed like RBQM trials. Learn how ISO 14155 and ICH E6(R3) align and download the practical translation guide.
From EMA Findings to ICH E6(R3): QbD and RBQM in Practice
How EMA inspection findings translate into ICH E6(R3) expectations, and why Quality by Design and RBQM must operate together in clinical trials.
Risk-based quality management in 2026
Risk-based quality management in 2026: how ICH E6(R3) defines RBQM, where practice diverges, and what regulators now expect in clinical trials.
FDA AI Guidance 2025 Interactive Visualizer
Explore how FDA’s 2025 AI guidance shapes lifecycle oversight for AI-enabled medical software through interactive regulatory scenarios.
ICH E6(R3) Interactive Visualizer: GCP Explained Visually
Explore the evolution of Good Clinical Practice with an interactive ICH E6(R3) visualizer showing ethics, risk-based oversight, and modern GCP design.
EMA Clinical Trials Map Visualizer Explained
Explore how the EMA Clinical Trials Map visualizes trial activity across Europe to support recruitment planning and site strategy decisions.
Decentralized Clinical Trials Outlook in the USA
Interactive visualizer exploring patient distribution, oncology expertise, and broadband access to support understanding of decentralized trial feasibility in the USA.
AI-Driven Predictive Analytics in Risk-Based Monitoring
Discover how AI-driven predictive analytics is reshaping risk-based monitoring under ICH E6(R3), enabling earlier intervention and stronger oversight.
The Cost of Poor Quality in Clinical Trials & How to Avoid It
Protocol changes and preventable risks can delay trials and drive major costs. Learn why proactive quality planning and RBQM lead to more predictable outcomes.
Phase III Oncology: Targeted Risk-Based QA Case Study
How ADAMAS used AI-augmented RBQM analytics to strengthen oversight, focus QA effort, and improve inspection readiness in a global Phase III oncology study.
